Page last updated: 2024-10-28

hydroxychloroquine and Bowel Diseases, Inflammatory

hydroxychloroquine has been researched along with Bowel Diseases, Inflammatory in 7 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Dyspnea is associated with a more severe infection."1.62Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. ( Algaba, A; Bermejo, F; Bonillo, D; Garza, D; Guerra, I; Jiménez, L; Mar Aller, M; Molina Esteban, LM, 2021)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Winthrop, KL1
Brunton, AE1
Beekmann, S1
Polgreen, P1
Baddley, J1
Saag, KG1
Calabrese, C1
Calabrese, L1
Robinson, PC1
Wallace, ZS1
Curtis, JR1
Guerra, I1
Algaba, A1
Jiménez, L1
Mar Aller, M1
Garza, D1
Bonillo, D1
Molina Esteban, LM1
Bermejo, F1
Abid, H1
Atmani, I1
Lahmidani, N1
El Yousfi, M1
Benajah, DA1
Ibrahimi, SA1
El Abkari, M1
Cooper, WO1
Cheetham, TC1
Li, DK1
Stein, CM1
Callahan, ST1
Morgan, TM1
Shintani, AK1
Chen, N1
Griffin, MR1
Ray, WA1
Wu, YH1
Chang, JY1
Chen, HM1
Wang, YP1
Knight, AK1
Cunningham-Rundles, C1
Cotton, P1

Reviews

1 review available for hydroxychloroquine and Bowel Diseases, Inflammatory

ArticleYear
Inflammatory and autoimmune complications of common variable immune deficiency.
    Autoimmunity reviews, 2006, Volume: 5, Issue:2

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived

2006

Other Studies

6 other studies available for hydroxychloroquine and Bowel Diseases, Inflammatory

ArticleYear
SARS CoV-2 infection among patients using immunomodulatory therapies.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized

2021
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
    Inflammatory bowel diseases, 2021, 01-01, Volume: 27, Issue:1

    Topics: Adult; Biological Therapy; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Dyspnea; Fema

2021
[Chronic inflammatory bowel diseases: what happens when SARS-CoV-2 occurs? Preliminary results from a study conducted at the Hassan II University Teaching Hospital in Fes, Morocco (a case report)].
    The Pan African medical journal, 2021, Volume: 38

    Topics: Adult; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Hospitals, University; Humans; Hydro

2021
Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.
    Arthritis & rheumatology (Hoboken, N.J.), 2014, Volume: 66, Issue:2

    Topics: Adult; Arthritis; Cohort Studies; Congenital Abnormalities; Female; Fetal Death; Follow-Up Studies;

2014
Pyostomatitis vegetans: An oral manifestation of inflammatory bowel disease.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:7

    Topics: Adult; Colchicine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inflammatory Bowel

2015
New approaches may aid patients with inflammatory bowel disease.
    JAMA, 1990, Jun-20, Volume: 263, Issue:23

    Topics: Aminosalicylic Acids; Cyclosporins; Fish Oils; Humans; Hydroxychloroquine; Inflammatory Bowel Diseas

1990